{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:39:31Z","timestamp":1791214771520,"version":"4.1.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T00:00:00Z","timestamp":1650672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T00:00:00Z","timestamp":1650672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Patients with an existing subcutaneous implantable cardiac defibrillator (S-ICD) may develop a pacing indication. When transvenous pacing is not feasible, combining an S-ICD and a leadless pacemaker (LP) can be a reasonable option. There are reports of concomitant use of both devices. However, the effect of pacing on the S-ICD sensing is not well studied. We hypothesise that pacing changes R and T-wave amplitudes, causing changes in R:T ratios as perceived by a S-ICD, increasing the risk for T wave oversensing (TWO) during paced rhythm with a subsequent risk of inappropriate shocks.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This is a prospective study in patients undergoing electrophysiological studies. Participants were fitted with a Holter\u00ae, and the leads were placed to correspond to the vectors of an S-ICD. The right ventricle was paced at four positions for 10 beats each at 8\u00a0mA\/2\u00a0ms. The Holter\u00ae traces were analysed, using two-way analysis of variance (ANOVA) to assess the effect of pacing on the R:T ratio.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Forty-seven patients (age 56.02\u2009\u00b1\u200916.02, 72% male) were enrolled (81% structurally normal heart, 15% dilated cardiomyopathy, 2% ischaemic cardiomyopathy, and 2% adult congenital heart disease). Age, sex, and aetiology had no effect on the R:T ratio. Pacing caused significant changes in the R:T ratio. There was no significant difference in the R:T ratios between the pacing sites (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Pacing alters the R:T ratio significantly in most patients, theoretically increasing the risk for TWO and inappropriate shocks. Tailored programming for both devices is important for concomitant use of LPs and S-ICDs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10840-022-01218-9","type":"journal-article","created":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T09:02:50Z","timestamp":1650704570000},"page":"31-42","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of right ventricular pacing site on the subcutaneous ICD sensing\u2014a step towards personalised device therapy?"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8481-1940","authenticated-orcid":false,"given":"Mohamed","family":"ElRefai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abouelasaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Menexi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,23]]},"reference":[{"issue":"7","key":"1218_CR1","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/EUROPACE\/EUT370","volume":"16","author":"DA Randles","year":"2014","unstructured":"Randles DA, Hawkins NM, Shaw M, Patwala AY, Pettit SJ, Wright DJ. How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation? EP Europace. 2014;16(7):1015\u201321. https:\/\/doi.org\/10.1093\/EUROPACE\/EUT370.","journal-title":"EP Europace"},{"issue":"5","key":"1218_CR2","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/JCE.12343","volume":"25","author":"LRA Olde Nordkamp","year":"2014","unstructured":"Olde Nordkamp LRA, Warnaars JLF, Kooiman KM, et al. Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening. J Cardiovasc Electrophysiol. 2014;25(5):494\u20139. https:\/\/doi.org\/10.1111\/JCE.12343.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"1218_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/J.HRTHM.2006.10.009","volume":"4","author":"RG Hauser","year":"2007","unstructured":"Hauser RG, Hayes DL, Kallinen LM, et al. Clinical experience with pacemaker pulse generators and transvenous leads: an 8-year prospective multicenter study. Heart Rhythm. 2007;4(2):154\u201360. https:\/\/doi.org\/10.1016\/J.HRTHM.2006.10.009.","journal-title":"Heart Rhythm"},{"issue":"18","key":"1218_CR4","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/EURHEARTJ\/EHT511","volume":"35","author":"RE Kirkfeldt","year":"2014","unstructured":"Kirkfeldt RE, Johansen JB, Nohr EA, Jorgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35(18):1186\u201394. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHT511.","journal-title":"Eur Heart J"},{"issue":"5","key":"1218_CR5","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/J.HRTHM.2011.12.014","volume":"9","author":"EO Udo","year":"2012","unstructured":"Udo EO, Zuithoff NPA, van Hemel NM, et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. 2012;9(5):728\u201335. https:\/\/doi.org\/10.1016\/J.HRTHM.2011.12.014.","journal-title":"Heart Rhythm"},{"issue":"6","key":"1218_CR6","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1056\/nejmoa1511643","volume":"374","author":"D Reynolds","year":"2016","unstructured":"Reynolds D, Duray GZ, Omar R, et al. A leadless intracardiac transcatheter pacing system. N Engl J Med. 2016;374(6):533\u201341. https:\/\/doi.org\/10.1056\/nejmoa1511643.","journal-title":"N Engl J Med"},{"issue":"12","key":"1218_CR7","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/J.HRTHM.2018.08.005","volume":"15","author":"MF El-Chami","year":"2018","unstructured":"El-Chami MF, Al-Samadi F, Clementy N, et al. Updated performance of the Micra transcatheter pacemaker in the real-world setting: a comparison to the investigational study and a transvenous historical control. Heart Rhythm. 2018;15(12):1800\u20137. https:\/\/doi.org\/10.1016\/J.HRTHM.2018.08.005.","journal-title":"Heart Rhythm"},{"issue":"6","key":"1218_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/J.HRCR.2015.07.009","volume":"1","author":"B Mond\u00e9sert","year":"2015","unstructured":"Mond\u00e9sert B, Dubuc M, Khairy P, Guerra PG, Gosselin G, Thibault B. Combination of a leadless pacemaker and subcutaneous defibrillator: first in-human report. HeartRhythm case reports. 2015;1(6):469\u201371. https:\/\/doi.org\/10.1016\/J.HRCR.2015.07.009.","journal-title":"HeartRhythm case reports"},{"issue":"1","key":"1218_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/JOA3.12140","volume":"35","author":"JB Ng","year":"2019","unstructured":"Ng JB, Chua K, Teo WS. Simultaneous leadless pacemaker and subcutaneous implantable cardioverter-defibrillator implantation\u2014when vascular options have run out. Journal of Arrhythmia. 2019;35(1):136. https:\/\/doi.org\/10.1002\/JOA3.12140.","journal-title":"Journal of Arrhythmia"},{"issue":"14","key":"1218_CR10","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/J.JACC.2007.09.073","volume":"51","author":"JP Daubert","year":"2008","unstructured":"Daubert JP, Zareba W, Cannom DS, et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51(14):1357\u201365. https:\/\/doi.org\/10.1016\/J.JACC.2007.09.073.","journal-title":"J Am Coll Cardiol"},{"key":"1218_CR11","doi-asserted-by":"publisher","unstructured":"Roberts PR, Clementy N, Samadi F al, et al. A leadless pacemaker in the real-world setting: the Micra Transcatheter Pacing System Post-Approval Registry. Heart Rhythm. 2017;14(9):1375\u20131379. https:\/\/doi.org\/10.1016\/J.HRTHM.2017.05.017","DOI":"10.1016\/J.HRTHM.2017.05.017"},{"key":"1218_CR12","doi-asserted-by":"publisher","unstructured":"Bongiorni MG, della Tommasina V, Barletta V, et al.Feasibility and long-term effectiveness of a non-apical Micra pacemaker implantation in a referral centre for lead extraction. EP Europace 2019; 21(1):114-120. https:\/\/doi.org\/10.1093\/EUROPACE\/EUY116","DOI":"10.1093\/EUROPACE\/EUY116"},{"issue":"10","key":"1218_CR13","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1111\/JCE.14083","volume":"30","author":"C Garweg","year":"2019","unstructured":"Garweg C, Vandenberk B, Foulon S, Haemers P, Ector J, Willems R. Leadless pacing with Micra TPS: a comparison between right ventricular outflow tract, mid-septal, and apical implant sites. J Cardiovasc Electrophysiol. 2019;30(10):2002\u201311. https:\/\/doi.org\/10.1111\/JCE.14083.","journal-title":"J Cardiovasc Electrophysiol"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-022-01218-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-022-01218-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-022-01218-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T15:47:28Z","timestamp":1739807248000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-022-01218-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,23]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["1218"],"URL":"https:\/\/doi.org\/10.1007\/s10840-022-01218-9","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,23]]},"assertion":[{"value":"10 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed with ethical approval from Health Research Authority (HRA)\u2014REC (20\/NW\/0366)\u2014and was also granted local research and development (RHMCAR0528) approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients gave informed written consent prior to recruitment in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Dr. Mohamed ElRefai is receiving unrestricted grant from Boston Scientific. Dr. Paul Roberts receives consultancy fees from Boston Scientific and Medtronic. Prof. John Morgan is a senior medical director at Boston Scientific. Other authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}